373 related articles for article (PubMed ID: 11296091)
1. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
Huestis MA; Gorelick DA; Heishman SJ; Preston KL; Nelson RA; Moolchan ET; Frank RA
Arch Gen Psychiatry; 2001 Apr; 58(4):322-8. PubMed ID: 11296091
[TBL] [Abstract][Full Text] [Related]
2. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users.
Huestis MA; Boyd SJ; Heishman SJ; Preston KL; Bonnet D; Le Fur G; Gorelick DA
Psychopharmacology (Berl); 2007 Nov; 194(4):505-15. PubMed ID: 17619859
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers.
Gorelick DA; Heishman SJ; Preston KL; Nelson RA; Moolchan ET; Huestis MA
Am Heart J; 2006 Mar; 151(3):754.e1-754.e5. PubMed ID: 16504646
[TBL] [Abstract][Full Text] [Related]
4. Antagonist-elicited cannabis withdrawal in humans.
Gorelick DA; Goodwin RS; Schwilke E; Schwope DM; Darwin WD; Kelly DL; McMahon RP; Liu F; Ortemann-Renon C; Bonnet D; Huestis MA
J Clin Psychopharmacol; 2011 Oct; 31(5):603-12. PubMed ID: 21869692
[TBL] [Abstract][Full Text] [Related]
5. CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men.
Goodwin RS; Baumann MH; Gorelick DA; Schwilke E; Schwope DM; Darwin WD; Kelly DL; Schroeder JR; Ortemann-Renon C; Bonnet D; Huestis MA
Am J Drug Alcohol Abuse; 2012 Jan; 38(1):114-9. PubMed ID: 21797816
[TBL] [Abstract][Full Text] [Related]
6. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine.
Williams CM; Kirkham TC
Pharmacol Biochem Behav; 2002; 71(1-2):333-40. PubMed ID: 11812541
[TBL] [Abstract][Full Text] [Related]
7. Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
Klumpers LE; Fridberg M; de Kam ML; Little PB; Jensen NO; Kleinloog HD; Elling CE; van Gerven JM
Br J Clin Pharmacol; 2013 Dec; 76(6):846-57. PubMed ID: 23601084
[TBL] [Abstract][Full Text] [Related]
8. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Darmani NA
Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
[TBL] [Abstract][Full Text] [Related]
9. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys.
Beardsley PM; Dance ME; Balster RL; Munzar P
Eur J Pharmacol; 2002 Jan; 435(2-3):209-16. PubMed ID: 11821028
[TBL] [Abstract][Full Text] [Related]
11. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.
Alonso R; Voutsinos B; Fournier M; Labie C; Steinberg R; Souilhac J; Le Fur G; Soubrié P
Neuroscience; 1999; 91(2):607-20. PubMed ID: 10366018
[TBL] [Abstract][Full Text] [Related]
12. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant.
Justinova Z; Munzar P; Panlilio LV; Yasar S; Redhi GH; Tanda G; Goldberg SR
Neuropsychopharmacology; 2008 Nov; 33(12):2870-7. PubMed ID: 18305459
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart.
Krylatov AV; Maslov LN; Lasukova OV; Pertwee RG
Bull Exp Biol Med; 2005 May; 139(5):558-61. PubMed ID: 16224548
[TBL] [Abstract][Full Text] [Related]
14. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
Järbe TU; Andrzejewski ME; DiPatrizio NV
Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
[TBL] [Abstract][Full Text] [Related]
16. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
[TBL] [Abstract][Full Text] [Related]
18. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
Mansbach RS; Rovetti CC; Winston EN; Lowe JA
Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
[TBL] [Abstract][Full Text] [Related]
19. SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats.
Deroche-Gamonet V; Le Moal M; Piazza PV; Soubrié P
Psychopharmacology (Berl); 2001 Sep; 157(3):254-9. PubMed ID: 11605080
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice.
Járai Z; Wagner JA; Goparaju SK; Wang L; Razdan RK; Sugiura T; Zimmer AM; Bonner TI; Zimmer A; Kunos G
Hypertension; 2000 Feb; 35(2):679-84. PubMed ID: 10679517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
